FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Fractyl Health, Inc. - Common Stock
(NQ:
GUTS
)
0.4066
UNCHANGED
Delayed Quote
Updated: 4:00 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Fractyl Health, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Fractyl Health Announces Clinical Results from German Real-World Registry Showing Meaningful and Sustained Weight Loss for at Least One Year After a Single Revita® Endoscopic Procedure
August 08, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
Fractyl Health to Report Second Quarter 2024 Financial Results and Provide Business Updates on August 14, 2024
August 07, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
Fractyl Health Receives FDA Breakthrough Device Designation for Revita in Weight Maintenance for People with Obesity Who Discontinue GLP-1 Based Drugs
July 30, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
Fractyl Health to Present at Piper Sandler 2nd Annual Virtual Obesity Day
June 25, 2024
Company will discuss recent corporate updates, including compelling preclinical data from Rejuva® pancreatic gene therapy platform, which was named top abstract at American Diabetes Association’s 84th...
From
Fractyl Health, Inc.
Via
GlobeNewswire
Fractyl Health Announces Advancement in Weight Maintenance Pipeline and Business Updates
June 24, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
Fractyl Health Presents New Preclinical Data on Sustained Weight Maintenance and Improved Body Composition from its Rejuva® Single-Administration GLP-1 Pancreatic Gene Therapy in President’s Select Oral Presentation at the American Diabetes Association’s
June 23, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
June 06, 2024
Via
Benzinga
Fractyl Health to Present New Preclinical Obesity Data from Rejuva® Platform at the American Diabetes Association’s 84th Scientific Sessions
May 29, 2024
Management to host in-person KOL event and webcast at ADA on Monday, June 24, 2024, at 7:00 a.m. ET
From
Fractyl Health, Inc.
Via
GlobeNewswire
Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva® at Digestive Disease Week 2024
May 20, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
GUTS Stock Earnings: Fractyl Health Beats EPS for Q1 2024
↗
May 13, 2024
GUTS stock results show that Fractyl Health beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates
May 13, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
Fractyl Health Presents Clinical Update on Revita® German Real-World Registry for Patients With Advanced Type 2 Diabetes (T2D)
May 13, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
Fractyl Health to Present at BofA Securities 2024 Health Care Conference
May 08, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
Fractyl Health to Report First Quarter 2024 Financial Results and Provide Business Updates on May 13, 2024
May 07, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
Fractyl Health Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference and the German Diabetes Association (DDG) Annual Meeting
April 30, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
The 3 Most Volatile Stocks for Short-Term Traders: April 2024
↗
April 17, 2024
Volatile stocks, as measured by their beta, offer short-term traders quick profit prospects whether the stock soars or nosedives.
Via
InvestorPlace
Why Cal-Maine Foods Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
↗
April 03, 2024
Shares of Cal-Maine Foods, Inc. (NASDAQ: CALM) rose sharply in today’s pre-market trading after the company reported upbeat results for its fourth quarter.
Via
Benzinga
Intel, XPeng And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
↗
April 03, 2024
U.S. stock futures were lower this morning, with the Nasdaq futures falling by around 0.2% on Wednesday.
Via
Benzinga
Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
April 02, 2024
Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss.
Via
Benzinga
Fractyl Health Expands Leadership with Appointment of Adrian Kimber as Chief Commercial Officer to Spearhead Anticipated Launch Preparation as the Company Conducts Two Pivotal Studies for Revita in Obesity and Type 2 Diabetes
April 02, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
PVH Posts Q4 Results, Joins Humana, CVS Health And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
↗
April 02, 2024
U.S. stock futures were lower this morning, with the Dow futures falling by over 100 points on Tuesday.
Via
Benzinga
Topics
Stocks
Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket
↗
April 01, 2024
Shares of Doma Holdings Inc. (NYSE: DOMA) rose sharply in today’s pre-market trading after the company entered a merger transaction with TRG to go private at $6.29 per share in cash. Doma Holdings...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
April 01, 2024
Via
Benzinga
Fractyl Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
April 01, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
Fractyl Health Receives FDA IDE Approval for the Revita® Remain-1 Pivotal Study of Weight Maintenance in Obesity after Discontinuation of GLP-1 Based Drugs
April 01, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
Top 5 Health Care Stocks Which Could Rescue Your Portfolio In March
↗
March 19, 2024
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
UPDATE -- Fractyl Health Announces New Results From Its Rejuva® Platform Demonstrating Potent and Durable Effects of a Single Dose of a Human GLP-1 Pancreatic Gene Therapy Transgene Compared to Semaglutide in the db/db Mouse Model of Diabetes and Obesity
March 12, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
Newly Listed Obesity Player Fractyl Health Shares Encouraging Preclinical Data
↗
March 12, 2024
Fractyl Health unveils RJVA-001, a groundbreaking GLP-1 gene therapy for metabolic diseases. Promising preclinical results show durable blood sugar and weight reduction in diabetes mouse model.
Via
Benzinga
Fractyl Health Announces New Results From Its Rejuva® Platform Demonstrating Potent and Durable Effects of a Single Dose of a Human GLP-1 Pancreatic Gene Therapy Transgene Compared to Semaglutide in the db/db Mouse Model of Diabetes and Obesity
March 12, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
↗
March 12, 2024
Pre-market stock movers are worth checking out this morning as we get into all of the biggest winners and losers for Tuesday!
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
Next >
